Shell Company Status. The Company is not, and has not been in the last twelve (12) months, an issuer identified in Rule 144(i)(1).
Appears in 7 contracts
Samples: Share Purchase Agreement (India Globalization Capital, Inc.), Purchase Agreement (India Globalization Capital, Inc.), Securities Purchase Agreement (India Globalization Capital, Inc.)
Shell Company Status. The Company is not, and has not been in at any time during the last twelve (12) months12 months preceding the date hereof, an issuer identified in Rule 144(i)(1).
Appears in 4 contracts
Samples: Securities Purchase Agreement, Securities Purchase Agreement (Adcare Health Systems Inc), Securities Purchase Agreement (Adcare Health Systems Inc)
Shell Company Status. The Company is notnot currently, and has not been in within the last twelve (12) 12 months, an issuer identified in in, or subject to, Rule 144(i)(1144(i).
Appears in 4 contracts
Samples: Securities Purchase Agreement (Pegasi Energy Resources Corporation.), Securities Purchase Agreement (WPCS International Inc), Securities Purchase Agreement (Crumbs Bake Shop, Inc.)
Shell Company Status. The Company is notnot currently, and has not been in within the last twelve (12) prior 12 months, an issuer identified in Rule 144(i)(1)) under the Securities Act.
Appears in 2 contracts
Samples: Purchase Agreement (Transenterix, Inc.), Purchase Agreement (Transenterix Inc.)
Shell Company Status. The Company is not, and has not been in for the last twelve (12) monthspreceding five years, an issuer identified in in, or subject to, Rule 144(i)(1144(i).
Appears in 2 contracts
Samples: Securities Purchase Agreement (Applied Dna Sciences Inc), Securities Purchase Agreement (Applied Dna Sciences Inc)
Shell Company Status. The Company is not, and has not been in at any time during the last twelve (12) monthstwelve-month period preceding the date hereof, an issuer identified in Rule 144(i)(1).
Appears in 1 contract
Samples: Securities Purchase Agreement (RADIENT PHARMACEUTICALS Corp)
Shell Company Status. The Company is not, and has not been in been, within the last twelve (12) months, months an issuer identified in Rule 144(i)(1144(i)(1)(i).
Appears in 1 contract
Samples: Securities Purchase Agreement (Oxygen Biotherapeutics, Inc.)
Shell Company Status. The Company is not, and has not been in at any time during the last twelve (12) months12 months preceding the date hereof, an issuer identified in Rule 144(i)(1)) promulgated under the Securities Act.
Appears in 1 contract
Samples: Securities Purchase Agreement (Adcare Health Systems Inc)
Shell Company Status. The Company is not, and has not been an issuer identified in Rule 144(i)(1)(i) during the last twelve (12) months, an issuer identified in Rule 144(i)(1).
Appears in 1 contract
Samples: Securities Purchase Agreement (Airborne Wireless Network)
Shell Company Status. The Company is notnot currently, and has not been in for the last past twelve (12) months, an issuer identified of the type described in paragraph (i) of Rule 144(i)(1)144 under the Securities Act.
Appears in 1 contract
Shell Company Status. The Company is notnot currently, and has not been in the last previous twelve (12) monthsmonths has not been, an issuer identified in Rule 144(i)(1)) under the Securities Act.
Appears in 1 contract
Samples: Exchange Agreement (Growlife, Inc.)
Shell Company Status. The Company is not, and has not been in the last twelve (12) months, an issuer identified in Rule 144(i)(1144(i)(1)(i).
Appears in 1 contract
Shell Company Status. The Company is not, and has not been in during the last twelve (12) monthspast five years been, an issuer identified in Rule 144(i)(1).
Appears in 1 contract
Samples: Stock Purchase Agreement (Maxwell Technologies Inc)
Shell Company Status. The Company is not, not currently and has not been in for the last past twelve (12) months, months an issuer identified in Rule 144(i)(1144(i)(1)(i).
Appears in 1 contract
Samples: Securities Purchase Agreement (Liqtech International Inc)
Shell Company Status. The Company is not, and has not been in the last twelve (12) months, an a “shell company” issuer identified as described in Rule 144(i)(1)144(i)(1)(i) for a period of at least twelve months from the date hereof.
Appears in 1 contract
Samples: Securities Purchase Agreement (Cure Pharmaceutical Holding Corp.)
Shell Company Status. The Company is not, and has not been in the last twelve (12) months, an issuer identified in Rule 144(i)(1).
Appears in 1 contract
Samples: Share Subscription Agreement (India Globalization Capital, Inc.)
Shell Company Status. The Company is not, and has not been in the last twelve (12) for a period of more than 12 months, an issuer identified in Rule 144(i)(1).
Appears in 1 contract
Shell Company Status. The Company is not, and has not been in the last twelve (12) preceding 12 months, an issuer identified in Rule 144(i)(1)) under the Securities Act.
Appears in 1 contract
Samples: Securities Purchase Agreement (Theralink Technologies, Inc.)
Shell Company Status. The Company is not, and has not been in for the last twelve (12) monthspast two fiscal years, an issuer identified in in, or subject to, Rule 144(i)(1144(i). The Company has, at least twelve months since it was last an issuer identified in, or subject to, Rule 144(i), filed all “Form 10 Information” pursuant to Rule 144(i).
Appears in 1 contract
Samples: Securities Purchase Agreement (VistaGen Therapeutics, Inc.)
Shell Company Status. The Company is not, and has not been in the last twelve past five (125) monthsyears been, an issuer identified in Rule 144(i)(1).
Appears in 1 contract
Samples: Series a Preferred Stock Purchase Agreement (Jaguar Health, Inc.)
